These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24126613)

  • 21. [Study on safty of standardized specific mite-allergen immunotherapy to children with allergic rhinitis and/or asthma].
    Wu Y; Long Z; Huang Y; Huang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul; 25(14):641-4. PubMed ID: 22032122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
    Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual immunotherapy for allergic rhinitis and conjunctivitis.
    Passalacqua G; Garelli V; Sclifò F; Canonica GW
    Immunotherapy; 2013 Mar; 5(3):257-64. PubMed ID: 23444955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLIT: indications, follow-up, and management.
    Dávila I; Navarro A; Domínguez-Ortega J; Alonso A; Antolín-Amérigo D; Diéguez MC; González-Mancebo E; Martíns C; Martínez C; Núñez B; Prior N; Rechel M; Rosado A; Ruiz-Hornillos J; Sansosti A; Torrecillas M; Jerez MJ; ;
    J Investig Allergol Clin Immunol; 2014; 24 Suppl 1():1-35. PubMed ID: 25011377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis.
    Sieber J; Köberlein J; Mösges R
    Curr Med Res Opin; 2010 Apr; 26(4):925-32. PubMed ID: 20163297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year).
    Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G
    Pediatr Allergy Immunol; 2007 Feb; 18(1):58-62. PubMed ID: 17295800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children.
    Tripodi S; Di Rienzo Businco A; Benincori N; Scala G; Pingitore G
    Int Arch Allergy Immunol; 2006; 139(2):149-52. PubMed ID: 16374025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of seasonal ultra-rush, high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents.
    Seidenberg J; Pajno GB; Bauer CP; La Grutta S; Sieber J
    J Investig Allergol Clin Immunol; 2009; 19(2):125-31. PubMed ID: 19476016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D; Keck T; Riechelmann H
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of sublingual immunotherapy in children.
    Frati F; Ridolo E; Fuiano N; Barberi S; Dell'Albani I; Landi M; Ricciardi L; Scala G; Incorvaia C
    Expert Opin Drug Saf; 2014 Jul; 13(7):947-53. PubMed ID: 24821477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once daily sublingual immunotherapy without updosing--A new treatment schedule.
    Rodriguez F; Boquete M; Ibáñez MD; de la Torre-Martínez F; Tabar AI
    Int Arch Allergy Immunol; 2006; 140(4):321-6. PubMed ID: 16741368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sublingual immunotherapy in the treatment of children.
    Pham-Thi N; de Blic J; Scheinmann P
    Allergy; 2006; 61 Suppl 81():7-10. PubMed ID: 16792599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites.
    Passalacqua G; Pasquali M; Ariano R; Lombardi C; Giardini A; Baiardini I; Majani G; Falagiani P; Bruno M; Canonica GW
    Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
    Giordano T; Quarta C; Bruno ME; Falagiani P; Riva G
    Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
    Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
    Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing and managing systemic reactions to immunotherapy.
    Ravi A; Rank MA
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):651-5. PubMed ID: 24145315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Certainties and doubts about sublingual and oral immunotherapy in children.
    Larenas-Linnemann D
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):558-67. PubMed ID: 19812482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
    Compalati E; Passalacqua G; Bonini M; Canonica GW
    Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.